Latest filing published 06 Sept 2019 for Luna Innovations INC, €411k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Clinic Carilion: trading record in brief
Clinic Carilion is a declared insider at 2 companies; the most frequent names are Luna Innovations Inc and Runway Growth Finance Corp. We count 61 filings; the first trade dates from 19 April 2017 and the latest from 6 September 2019.
Market trades split into 7 purchases (€21.3M) and 50 sales (€8.1M). The net balance comes to €13.2M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants and 1 option exercise. So far in 2019, the count stands at 2 purchases and 31 sales.
Half of the purchases are above €2.5M and half below.
Most recently, on 6 September 2019, the filings show an open-market sale worth €411k in Luna Innovations Inc. The clock since the last published purchase (14 May 2019) now reads 2,735 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Clinic Carilion
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 71,701 shares@ US$6.324.9% of flowCommon StockSEC:0001239819-19-000121:0
- 48,953 shares@ US$6.713.5% of flowCommon StockSEC:0001239819-19-000121:1
- 51,047 shares@ US$6.703.7% of flowCommon StockSEC:0001239819-19-000121:2
- 53,265 shares@ US$6.353.6% of flowCommon StockSEC:0001239819-19-000113:0
- 83,634 shares@ US$6.395.8% of flowCommon StockSEC:0001239819-19-000113:1
- 109,604 shares@ US$6.307.4% of flowCommon StockSEC:0001239819-19-000109:0
- 81,796 shares@ US$6.215.4% of flowCommon StockSEC:0001239819-19-000109:1
- 52,220 shares@ US$6.253.5% of flowCommon StockSEC:0001239819-19-000107:0
- 47,780 shares@ US$6.223.2% of flowCommon StockSEC:0001239819-19-000107:1
- 51,699 shares@ US$6.063.3% of flowCommon StockSEC:0001239819-19-000105:0
- 48,301 shares@ US$6.073.1% of flowCommon StockSEC:0001239819-19-000105:1
- 29,768 shares@ US$6.021.8% of flowCommon StockSEC:0001239819-19-000103:0
- 68,732 shares@ US$6.044.2% of flowCommon StockSEC:0001239819-19-000103:1
- 1,500 shares@ US$6.010.1% of flowCommon StockSEC:0001239819-19-000103:2
- 23,336 shares@ US$5.621.3% of flowCommon StockSEC:0001239819-19-000101:0
- 55,969 shares@ US$5.573.1% of flowCommon StockSEC:0001239819-19-000101:1
- 83,861 shares@ US$5.614.7% of flowCommon StockSEC:0001239819-19-000099:0
- 36,834 shares@ US$5.702.1% of flowCommon StockSEC:0001239819-19-000099:1
- 54,495 shares@ US$5.252.9% of flowCommon StockSEC:0001239819-19-000097:0
- 42,200 shares@ US$5.352.3% of flowCommon StockSEC:0001239819-19-000091:0
- 3,305 shares@ US$5.250.2% of flowCommon StockSEC:0001239819-19-000091:1
- 7,154 shares@ US$5.000.4% of flowCommon StockSEC:0001239819-19-000089:0
- 17,178 shares@ US$5.020.9% of flowCommon StockSEC:0001239819-19-000089:1
- 13,466 shares@ US$5.000.7% of flowCommon StockSEC:0001239819-19-000087:0
- 1,113 shares@ US$5.000.1% of flowCommon StockSEC:0001239819-19-000087:1
25 of 61 declarations